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Pathological hallmarks indicative of Alzheimer’s disease (AD), which are the plaques of
amyloid beta1–42 and neurofibrillary tangles, were found in brain of aged cynomolgus mon-
key. The aim of this study was to investigate if aged monkeys exhibiting spatial memory
impairment and levels of biomarkers indicative of AD, had brain lesions similar to human
patients suffering from senile dementia. Generating immunohistochemistry technique to
biomarkers of amyloid beta1–42 and the phosphorylated tau 231, our study assessed the
amyloidopathy, such as indicative to the senile plaques and cerebral amyloid angiopathy, and
the tauopathy, to possible neurofibrillary tangles. Six aged monkeys were selected based
on their spatial memory performance and profile of biomarkers of AD, divided equally to
affected aged subject – with Memory-affected and low amyloid level, and aged with higher
performance in memory and amyloid, as the age-matched subjects. Using immunohisto-
chemistry, plaques of amyloid beta1–42 were observed in two out of three brains of aged
subjects with memory impairment and biomarkers indicative of AD. The cerebral amy-
loid angiopathy was observed in both aged monkey groups, and unlike in the human, the
amyloids were found to deposit in the small veins and capillaries. In one of the affected
individuals, phosphorylated tau was positively stained intracellularly of the neurons, indi-
cating a possibility of an early stage of the formation of tangles. These findings add to the
body of evidence of the utility of the aged cynomolgus monkeys as a spontaneous model
for Alzheimer-related disease.
Keywords: degenerative disease, immunohistochemistry, senile plaques, neurofibrillary tangles, cerebral amyloid
angiopathy
INTRODUCTION
Tests for several behavioral tasks, developed within the human
neuropsychological domain, have been successfully adapted for
use with non-human primates (NHP), including delayed response
tasks (DRT) (Amici et al., 2010) where delays of various lengths are
imposed between the presentation of a stimulus and the desired
response (Bartus and Dean, 2009; Lacreuse and Herndon, 2009;
Rodriguez and Paule, 2009; Nagahara et al., 2010). This type of
memory tests is appropriate in assessing Alzheimer’s disease (AD),
and as well as other affected cognitive function such as executive
function and divided attention (Johannsen et al., 1999; Gian-
nakopoulos et al., 2007). As some of the earliest cerebral lesions
in the AD progression are typically located in the hippocampus
(Deiana et al., 2011), spatial memory tests are of particular interest.
Delayed response tasks performance in cynomolgus monkeys
(Macaca fascicularis) has recently been described (Darusman et al.,
2013a) demonstrating that old monkeys (more than 20 years of
age) performed poorer than young (4–9 years) and middle aged
(10–16 years) individuals. The DRT performance was correlated
with the levels of the core biomarkers indicative of AD, espe-
cially the amyloid-beta1–42 (Aβ42) (Darusman et al., 2013b, 2014),
where the DRT performance was positively correlated with con-
centrations of Aβ42. Structural magnetic resonance imaging (MRI)
studies identified abnormalities, such as atrophy in hippocampus
and morphological changes in the cortical areas in aged monkeys
with poor memory and low Aβ42 levels (Darusman et al., 2014).
Earlier studies of brain sections from older cynomolgus mon-
key revealed pathological hallmarks indicative of AD (Nakamura
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et al., 1998), and based on the combined findings described above,
the present study was carried out to investigate whether animals
with poor DRT performance and circulating biomarkers levels
indicative of senile dementia also exhibited brain lesions such as
senile plaques (SP) of Aβ42 and tauopathy. In the human, the
progression of cognitive decline and biomarkers levels reflect the
AD pathological processes in the brain (Andreasen and Blennow,
2005; Perrin et al., 2009). Low levels of circulating Aβ42 and ele-
vated total tau (t-tau) and phosphorylated tau (p-tau), are related
with the development of SP and NFT, respectively (Brody et al.,
2008; Blennow et al., 2010; Jack et al., 2010; Albert et al., 2011). In
rhesus monkeys, the incidence, distribution, and chemical compo-
sition of the Aβ deposits in the brain of young and aged individuals
have been described (Sani et al., 2003; Nishimura et al., 2012) with
higher level of Aβ1–40 (Aβ40) than the Aβ42.
In the present study, we examined the presence of Aβ42 and
the p-tau by immunohistochemistry analysis in brain sections of
aged monkeys selected from a previous study (Darusman et al.,
2013a,b), based on low total DRT and low levels of Aβ42 in
cerebrospinal fluid (CSF) compared with aged monkeys with bet-
ter memory performance and high CSF Aβ42 levels. The DRT
were assessed by the short term memory test (STMT), long term
memory test (LTMT), and memory load test (MLT).
MATERIALS AND METHODS
SUBJECTS
From previous studies, we selected aged subjects above 20 years old
that met the requirements of low levels of Aβ42(<5000 pg/ml) and
low DRT performance (<40%) for the memory-affected group
(Darusman et al., 2013a,b). Aged subjects characterized by high-
circulating Aβ42 and high DRT performance were selected for
the age-matched control group. Subject age was determined from
birth certificates for the animals born in captivity and from dental
scaling (Swindler, 2002) and estimated year of born for animals
born in the wild.
The subjects in this study (Table 1) were limited to old individ-
uals that were destined for euthanasia due to progressive weight
loss, paleness of the mucous membranes, reduced appetite, and/or
general weakness. These criteria yielded three memory-affected
monkeys (two females and one male), and three age-matched
monkeys (one female and two males). Two young monkeys (one
female and one male) were included to control for potential
confounds associated with age.
All subjects were housed at the AAALAC-accredited Primate
Research Center, Bogor Agricultural University (PRC, IPB) in pairs
or social groups of various sizes. During the testing period, the sub-
jects were individually housed indoors in adjacent cages, which
permitted some tactile contact through perforated acrylic pan-
els. The subjects’ housing conditions and test procedures were
approved by the PRC IPB Animal Care and Use Committee. The
subjects’ characteristics with their previous DRT performance and
biomarker levels are presented in Table 1.
HISTOPATHOLOGY
The animals were euthanized with pentobarbital and phenytoin
injections (Euthasol™, Virbac, Fort Worth, TX, USA) followed by
intracardial sodium chloride 0.9% perfusions and exsanguination;
the intracardial perfusion was continued with paraformaldehyde
(4%). Brains were collected and immersed in 10% paraformalde-
hyde solution for 24 h. Subsequently, the brains were fixated
in buffered formalin 10% (pH 7). Fixated brains were sec-
tioned in the coronal plane allowing for analyses of five distinct
regions: the frontal, occipital, parietal and temporal lobes, and the
hippocampus.
All sections were embedded in paraffin wax and cut into 5µm
sections. Hematoxylin-eosin (HE) staining was applied for routine
examination of the brain, especially for observing degeneration
signs (apoptotic neuron signs such as chromatolysis, gliosis, vac-
uolization) because we were not applying immunohistochemistry
studies of these degeneration signs. Congo-red staining was also
applied to observe amyloid in general. For immunohistochemistry
of Aβ42 and p-tau, sections were treated with sodium citrate buffer
at 95°C for 30 min, and to minimize non-specific binding, sections
were treated with 3% hydrogen peroxide in methanol for 30 min
at room temperature, and blocked using 1% fetal bovine serum
and 10% skimmed milk in PBS for 30 min at room temperature.
Table 1 |The characteristics of the subjects.
Tattoo/sex/age group Total DRT (%) Biomarker (pg/ml) Reference Agea
Aβ42 t-tau pT231
C2538/female/young 68.09 655.10 301.60 2.36 Darusman et al. (2013a) 9
C0744/male/young 60.50 620.00 568.60 6.27 Darusman et al. (2013a) 7
10063/female/memory-affected 40.58 16.01 92.62 4.81 Darusman et al. (2013b) 30
T3311/male/memory-affected 40.00 368.36 319.46 4.19 Darusman et al. (2013a) 30b
I1112/female/memory-affected 34.34 164.96 219.85 5.45 Darusman et al. (2013a) 29
10749/female/age-matched 61.67 416.36 370.57 4.11 Darusman et al. (2013b) 30
9661/male/age-matched 60.16 480.76 277.71 7.55 Darusman et al. (2013b) 27
T3283/male/age-matched 66.42 524.65 60.64 4.37 Darusman et al. (2013b) 30b
Data are collected from the references Darusman et al. (2013a,b). DRT performance is presented as the collected percent of trials where the subject could correctly
retrieve a hidden item following a predetermined delay. Biomarker levels were measured in serum and CSF.
aUp to the end of year of 2013.
bEstimated from the year of birth by a population survey in 1983.
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An AD detection kit (Millipore™, Temecula, CA, USA) was used
to identify Aβ42 and p-tau threonine 231 (pT231). The kit con-
tained polyclonal antibodies against human Aβ42 (catalog number
AB5078P) and pT231 (catalog number MAB3420SP).
The sections were incubated with the specific antibodies
(diluted 1:500 in PBS) overnight at 4°C. After washing with PBS,
the sections were incubated with a biotinylated secondary antibody
for 30 min, and subsequently with Streptavidin-Horse Radish Per-
oxidase (HRP) for 30 min at room temperature (DAKO-LSAB+
system HRP kit; Glostrup, Denmark). Diaminobenzidine (DAB)
was applied at room temperature until an appropriate inten-
sity was obtained (2–5 min). Sections were rinsed in distilled
water, counterstained with HE to visualize tissue morphology
and then mounted with Entellan® (product number 1079610100,
Merck KGaA, Darmstadt, Germany). Negative controls (with-
out secondary antibody), antibody control (treated with normal
rabbit serum), and photomicrograph control, were included. All
slides (three slides for each brain region, times each staining
procedure were analyzed for each subject; i.e., 3× 5× 7= 105)
were scored independently by two trained pathologists that were
blinded to the identity of the individuals. Scores are summarized
in Table 2.
The degeneration score follows the progression of the apoptotic
nerve cell (Kettemann et al., 2011). The degree of chromatolysis
and the number of satellite cells or glial cells (Gliosis) was also
incorporated in the degeneration score (Chen et al., 2013). Two
aspects of amyloidopathy were scored: cerebral amyloid angiopa-
thy (CAA) and SP (Heuer et al., 2012), where CAA scores were
based on the localization of Aβ42 (Attems and Jellinger, 2004)
and plaques were scored by morphology (lowest score was valued
when the plaques appeared as small numbers and diffused, contin-
ued with compacted formation and compacted plaques with sign
of degeneration surrounding as the highest score). The tauopa-
thy was scored based on which stage the tangles formation was
perceived to be in Augustinack et al. (2002).
RESULTS
DEGENERATION
The histopathology findings (scores and the lobes where the lesion
appeared) are presented in Table 3. Signs of brain degeneration
were found in the aged monkeys, both the memory-affected and
aged-matched subjects. Degeneration signs such as gliosis and vac-
uolization were present in the brains of all aged, but not in young
animals. Early signs of degeneration were found in young animals,
Table 2 | Scoring criteria of the histopathology of the brain.
Score Degeneration Amyloid disorders Tauopathy
CAA Senile plaques
1 Condensed chromatin inside nuclei
(chromatolysis)
Deposit of amyloid in
vascular wall of
arterioles
Diffused plaques – appearing as small
numbers of nodules in the brain
parenchyma
p-tau detected inside the
cytoplasm of the neuron
(intracellular stage)
2 Aggregation of satellite cell/glial cell
(gliosis)
Deposit of amyloid in
vascular wall of
venules
Compacted plaques – appearing in
larger amounts and sizes in the brain
parenchyma
p-tau detected in the
cytoplasm and/or axon of the
neuron (fibrillar stage)
3 Formation of vacuole sites as indicative
of active phagocytosis of the
degenerated neuron (vacuolization)
Deposit of amyloid in
vascular wall of
capillaries
Compacted plaques in the brain
parenchyma associated with
degeneration of the surrounding nerve
p-tau detected as tangled
formations outside of the
neuron (extracellular stage)
Table 3 | Histopathology findings and summary of the scores.
Tattoo Group Average score from two observers (lobesa)
Degeneration CAA Senile plaques Tauopathy
C2538 Young 1(P) 0 0 0
C0744 Young 1(P) 0 0 0
10063 Memory-affected 2(F), 2(P), 1(O), 1(Hip) 3(F), 2(T) 0 0
T3311 Memory-affected 3(F), 2(T), 1(Hip) 3(F), 2(P), 1(O) 2(F), 1(P), 1(Hip) 0
I1112 Memory-affected 3(F), 2(T), 1(O), 1(P), 1 (Hip) 2(F), 2(T), 1(O), 1(P), 1 (Hip) 2(F), 1(T), 1(O), 1(Hip) 1 (T), 1 (O)
10749 Age-matched 3(F), 2(P) 2 (F), 2(T), 1(Hip) 0 0
9661 Age-matched 3 (F), 2 (P) 2 (F), 1(T), 1(P) 0 0
T3283 Age-matched 2(F), 2 (P), 1(O) 2(F), 2 (T), 1 (O) 0 0
aF, frontal lobe; T, temporal lobe; P, parietal lobe; O, Occipital lobe; Hip, hippocampus.
Frontiers in Aging Neuroscience www.frontiersin.org November 2014 | Volume 6 | Article 313 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Darusman et al. Amyloid and p-tau in brain of aged monkeys
observed as a chromatolysis, while the later stages – the gliosis
and vacuolization – were only observed in aged animals, both the
memory-affected and age-matched subjects. These degeneration
signs were observed in the frontal lobe of all the aged subjects
(n= 6), in the parietal lobe of most (n= 5), and in the temporal
and occipital lobes of some (n= 2). A degeneration of the hip-
pocampus was found only in the memory-affected aged monkeys
observed as chromatolysis.
CAA
The CAA was found in the small vessels of the brain in all
of the aged monkeys. Brown coloration from DAB appeared in
the vascular wall of the brain capillaries, preferentially in small
veins (Figure 1). The CAA was observed in the blood vessels
of the frontal lobe (n= 6), temporal lobes (n= 5), occipital
and parietal lobes (each n= 3), and hippocampus (n= 2). The
CAA was observed in the capillaries of the frontal lobe in the
Memory-affected monkeys (n= 2).
SENILE PLAQUES
Plaques of Aβ42 in the parenchyma were observed in the brain
from two monkeys of the memory-affected group (Figure 2); sub-
jects I1112 and T3311. The plaques were principally found in the
frontal, temporal and parietal lobes, and the hippocampus. The
compacted shape of the plaques was observed only in frontal lobes,
while the diffused shapes were found in the other aforementioned
lobes.
TAUOPATHY
The pT231 was found in the temporal and occipital lobe from
one subject belonging to the memory-affected group (I1112). The
pT231-positive structures appeared only in the cytoplasm of the
neuron cell (Figure 3). The brownish colorization from the pT231
antibody was weaker compared with the other DAB staining of the
SP and CAA.
DISCUSSION
In addition to degenerative lesions, such as the microgliosis and
vacuolization, we found the CAA in both aged groups and not in
the young individuals – defined by an accumulation of amyloid
beta in the brain vascular wall: cerebral beta-amyloid angiopathy
(Rensink et al., 2003; Revesz et al., 2003, 2009; Greenberg et al.,
2004). Since both aged groups developed the CAA, it suggested
that the CAA may occur spontaneously in cynomolgus monkeys
as in other aged NHP species, such as Rhesus monkeys (Walker,
1997; Heuer et al., 2012).
Qualitatively, the CAA in the memory-affected and aged-
matched groups shared same relative amounts and similar to
location in lobes where the lesions were present, namely the frontal
and parietal-temporal lobes, which are the brain lobes related to
FIGURE 1 | (A) Brain section from the temporal lobe of a memory-affected
animal (subject T3311) treated with a polyclonal serum against human Aβ42
and stained with DAB. The inset picture is a photomicrograph control treated
with nonsense rabbit serum. (B)The occipital lobe of an Aged-matched subject
(subject 10749); and (C) the hippocampus (subject I1112) arrows indicate
deposition of the Aβ42 inside the walls of small veins. Scale bars: 60µm.
FIGURE 2 | Brain section of the frontal lobe from a Memory-affected animal (subject I1112) demonstrating Aβ42 plaques in the parenchyma, (A) stained
with HE, (B) Congo red and (C) with anti-Aβ42 antiserum/DAB, and (D) HE from Aged-matched subject (subject 10749). Arrows indicate Aβ42 plaques.
Scale bars: 60µm.
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FIGURE 3 |The occipital lobe of an age-matched subject (T3283)
(A), the occipital lobe of a memory-affected subject (I1112)
(B), and temporal lobe (C). Sections have been treated with a
polyclonal serum against human p-tau pT231 and stained with DAB.
Arrows indicate the presence of pT231 in the cytoplasm of nerve
cells. Scale bars: 60µm.
memory function and also affected in AD and frontotemporal
disease (FTD) in the human (Naggara et al., 2006; Rodriguez and
Paule, 2009; Heuer et al., 2012), along with the hippocampus area
(Johannsen et al., 2000; Deiana et al., 2011). CAA is present in
almost in all cases of AD (Okamoto et al., 2009, 2012).
In humans, CAA is most prominent in the arterioles and less
frequent in veins and capillaries (Preston et al., 2003), while inter-
estingly our findings showed that amyloid beta deposits in the
small veins and capillaries of the cynomolgus monkey. More thor-
ough study of the mechanism of Aβ deposition in the veins is
required in order to confirm whether or not the Aβ internalizes
into endothelial cells, from blood passing through capillary pores,
and thereby becomes detectable inside the vessel wall of veins and
capillaries. The suspected CAA inside the capillaries and small
veins correlates with AD pathology (Attems and Jellinger, 2004)
and cognitive impairment (Eurelings et al., 2010). Our findings
thus support studies of CAA in other aged old world monkeys
(Walker, 1997; Nakamura et al., 1998; Oikawa et al., 2010).
In rhesus monkey and cynomolgus monkey, CAA and the
parenchymal plaques of amyloid beta, are correlated (Nakamura
et al., 1998; Levine and Walker, 2006) and our findings may sup-
port this. Our findings suggest that memory impaired cynomolgus
monkeys suffer from an amyloid-related disease manifested as
SP in the brain. On the other hand, animals with spontaneous
amyloid-like disorder such as the dog with canine cognitive dys-
function had a fundamentally different relationship between the
cognitive disorder and the retention of amyloid load sensitive
marker Pittsburgh compound B (Fast et al., 2013).
Among three Memory-affected subjects, we found two sub-
jects (I1112 and T3311) with the parenchymal form of amyloid
beta inside the frontal, temporal lobes, and the hippocampus. The
plaques were present in the same lobes where CAA was found.
In the rhesus monkey, the deposits of Aβ were observed princi-
pally in the cortical, paralimbic, and core limbic cortical zones
corresponding to mild, moderate, and heavy burden, respectively
(Sani et al., 2003). Along with Nishimura et al. (2012), this study
of rhesus monkeys also emphasizes the higher proportion of Aβ40
compared with the Aβ42. The absence of Aβ40 analysis in our study
seems limit the whole interpretation.
However, another study in the species showed that the Aβ42
often predominate the Aβ40 in the cortical level of both tem-
poral and occipital lobes, although the relative level of Aβ40
remain higher in the occipital cortex (Rosen et al., 2011). The
additional immunohistochemistry of Aβ40 could add more infor-
mation about the proportion of the Aβ in the cynomolgus monkey.
This would support a biomarker study by Yue et al. (2014), which
describes that Aβ42 was significantly associated with aging but not
with the Aβ40 in cynomolgus monkey.
Similar to other studies (Oikawa et al., 2010; Heuer et al., 2012),
we also found signs of both nerve damage and tangle formation in
the brain of aged monkeys although the location of the plaques and
the tangles were not correspondently the same. An old female from
the memory-affected group (I1112), which had the parenchymal
form of amyloid beta stained positively for pT231 in the body of
nerve cells in the temporal and occipital lobes. In AD patients, this
is the early stage of NFT, indicated by the intracellular form of
NFT (Augustinack et al., 2002). The identified p-tau in the neu-
ron’s cytoplasm was not corresponded with the SP, showed by the
differences of the lobes’ location between SP and p-tau. This find-
ing agrees with a previous study in cynomolgus monkey (Oikawa
et al., 2010) that the pathological differences of SP and tauopa-
thy in the species is specific and may differed with human’s AD
pathology.
Although the present study was small, it adds to the body of
evidence (Oikawa et al., 2010; Heuer et al., 2012) that support
the neuropathology of the aged cynomolgus monkey as a poten-
tial model for studies of spontaneous disease of Alzheimer-type,
especially the amyloid-related brain pathology and also suggests
the potential for further study of p-tau mediated pathology in
the species (Walker, 1997; Levine and Walker, 2006; Oikawa et al.,
2010; Heuer et al., 2012). Future studies of high relevance would
include more detailed analyses of the Aβ40, Aβ42, and the pT231
presence in each of the brain lobes to confirm the expression of
both biomarkers and to complement the histopathology results.
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